Open AccessSuper-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapy
Author(s) -
Ammar M. Killu,
Anna Mazo,
Avishay Grupper,
Malini Madhavan,
Tracy L. Webster,
Kelly L. Brooke,
David O. Hodge,
Samuel J. Asirvatham,
Paul A. Friedman,
Michael Glikson,
YongMei Cha
Publication year - 2017
Publication title -
ep europace
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.119
H-Index - 102
eISSN - 1532-2092
pISSN - 1099-5129
DOI - 10.1093/europace/eux235
Subject(s) - medicine , cardiac resynchronization therapy , implantable cardioverter defibrillator , cardiology , hazard ratio , ejection fraction , confidence interval , heart failure , defibrillation , cardiac function curve
To determine the frequency of implantable cardioverter defibrillator (ICD) therapy following cardiac resynchronization therapy (CRT-D) implantation in super and non-super responders and whether greater improvement in left ventricular (LV) function after CRT is associated with a reduced burden in ICD therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom